Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Bispecific Antibody Therapeutic market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Bispecific Antibody Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by Bispecific Antibody Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
By Type:
Bearing An Fc Region
Lacking An Fc Region
By End-User:
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bispecific Antibody Therapeutic Market
-
1.3 Market Segment by Type
-
1.3.1 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Bearing An Fc Region from 2016 to 2027
-
1.3.2 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Lacking An Fc Region from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Osteology from 2016 to 2027
-
1.4.2 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Pulmonary from 2016 to 2027
-
1.4.3 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027
-
1.4.4 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.5 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Gene Therapy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bispecific Antibody Therapeutic Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bispecific Antibody Therapeutic by Major Types
-
3.4.1 Market Size and Growth Rate of Bearing An Fc Region
-
3.4.2 Market Size and Growth Rate of Lacking An Fc Region
4 Segmentation of Bispecific Antibody Therapeutic Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bispecific Antibody Therapeutic by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bispecific Antibody Therapeutic in Osteology
-
4.4.2 Market Size and Growth Rate of Bispecific Antibody Therapeutic in Pulmonary
-
4.4.3 Market Size and Growth Rate of Bispecific Antibody Therapeutic in Respiratory Diseases
-
4.4.4 Market Size and Growth Rate of Bispecific Antibody Therapeutic in Oncology
-
4.4.5 Market Size and Growth Rate of Bispecific Antibody Therapeutic in Gene Therapy
5 Market Analysis by Regions
-
5.1 China Bispecific Antibody Therapeutic Production Analysis by Regions
-
5.2 China Bispecific Antibody Therapeutic Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Bispecific Antibody Therapeutic Landscape Analysis
-
6.1 North China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
6.2 North China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
7 Central China Bispecific Antibody Therapeutic Landscape Analysis
-
7.1 Central China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
7.2 Central China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
8 South China Bispecific Antibody Therapeutic Landscape Analysis
-
8.1 South China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
8.2 South China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
9 East China Bispecific Antibody Therapeutic Landscape Analysis
-
9.1 East China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
9.2 East China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
10 Northeast China Bispecific Antibody Therapeutic Landscape Analysis
-
10.1 Northeast China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
10.2 Northeast China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
11 Southwest China Bispecific Antibody Therapeutic Landscape Analysis
-
11.1 Southwest China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
11.2 Southwest China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
12 Northwest China Bispecific Antibody Therapeutic Landscape Analysis
-
12.1 Northwest China Bispecific Antibody Therapeutic Landscape Analysis by Major Types
-
12.2 Northwest China Bispecific Antibody Therapeutic Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Creative-biolabs
-
13.1.1 Creative-biolabs Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 PharmAbcine
-
13.2.1 PharmAbcine Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sorrento Therapeutics
-
13.3.1 Sorrento Therapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Patheon
-
13.4.1 Patheon Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Bearing An Fc Region from 2016 to 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Lacking An Fc Region from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Osteology from 2016 to 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Pulmonary from 2016 to 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Gene Therapy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bispecific Antibody Therapeutic Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bispecific Antibody Therapeutic
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bispecific Antibody Therapeutic by Different Types from 2016 to 2027
-
Table Consumption Share of Bispecific Antibody Therapeutic by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Bearing An Fc Region
-
Figure Market Size and Growth Rate of Lacking An Fc Region
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bispecific Antibody Therapeutic by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bispecific Antibody Therapeutic by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Osteology
-
Figure Market Size and Growth Rate of Pulmonary
-
Figure Market Size and Growth Rate of Respiratory Diseases
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Gene Therapy
-
Table China Bispecific Antibody Therapeutic Production by Regions
-
Table China Bispecific Antibody Therapeutic Production Share by Regions
-
Figure China Bispecific Antibody Therapeutic Production Share by Regions in 2016
-
Figure China Bispecific Antibody Therapeutic Production Share by Regions in 2021
-
Figure China Bispecific Antibody Therapeutic Production Share by Regions in 2027
-
Table China Bispecific Antibody Therapeutic Consumption by Regions
-
Table China Bispecific Antibody Therapeutic Consumption Share by Regions
-
Figure China Bispecific Antibody Therapeutic Consumption Share by Regions in 2016
-
Figure China Bispecific Antibody Therapeutic Consumption Share by Regions in 2021
-
Figure China Bispecific Antibody Therapeutic Consumption Share by Regions in 2027
-
Table North China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table North China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table North China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table North China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure North China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table Central China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table Central China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table Central China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Central China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure Central China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table South China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table South China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table South China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table South China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure South China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table East China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table East China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table East China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table East China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure East China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table Northeast China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table Northeast China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table Northeast China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Northeast China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure Northeast China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table Southwest China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table Southwest China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table Southwest China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Southwest China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure Southwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table Northwest China Bispecific Antibody Therapeutic Consumption by Types from 2016 to 2027
-
Table Northwest China Bispecific Antibody Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2016
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2021
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by Types in 2027
-
Table Northwest China Bispecific Antibody Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Northwest China Bispecific Antibody Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2016
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2021
-
Figure Northwest China Bispecific Antibody Therapeutic Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Creative-biolabs
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creative-biolabs
-
Figure Sales and Growth Rate Analysis of Creative-biolabs
-
Figure Revenue and Market Share Analysis of Creative-biolabs
-
Table Product and Service Introduction of Creative-biolabs
-
Table Company Profile and Development Status of PharmAbcine
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmAbcine
-
Figure Sales and Growth Rate Analysis of PharmAbcine
-
Figure Revenue and Market Share Analysis of PharmAbcine
-
Table Product and Service Introduction of PharmAbcine
-
Table Company Profile and Development Status of Sorrento Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics
-
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics
-
Figure Revenue and Market Share Analysis of Sorrento Therapeutics
-
Table Product and Service Introduction of Sorrento Therapeutics
-
Table Company Profile and Development Status of Patheon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Patheon
-
Figure Sales and Growth Rate Analysis of Patheon
-
Figure Revenue and Market Share Analysis of Patheon
-
Table Product and Service Introduction of Patheon
-
